Elicio Therapeutics, Inc.
SEC Filing List
ELTX CIK: 0001601485
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| 424B5 | Prospectus filed pursuant to Rule 424(b)(5) | Elicio Therapeutics, Inc. | Toppan Merrill/FA | 07/02/2026 | |
| 8-K | Current report filing | Elicio Therapeutics, Inc. | Toppan Merrill/FA | 07/02/2026 | |
| 8-K | Current report filing | Elicio Therapeutics, Inc. | 06/24/2026 | ||
| 8-K | Current report filing | Elicio Therapeutics, Inc. | 06/17/2026 | ||
| 8-K | Current report filing | Elicio Therapeutics, Inc. | 06/15/2026 | ||
| 10-Q | Quarterly report pursuant to Section 13 ... | Elicio Therapeutics, Inc. | 05/11/2026 | ||
| 8-K | Current report filing | Elicio Therapeutics, Inc. | 05/11/2026 | ||
| 10-K/A | Amendment to annual report pursuant to S... | Elicio Therapeutics, Inc. | 04/29/2026 | ||
| 424B5 | Prospectus filed pursuant to Rule 424(b)(5) | Elicio Therapeutics, Inc. | Workiva Inc. Wdesk FA01 /fa | 03/16/2026 | |
| 8-K | Current report filing | Elicio Therapeutics, Inc. | 03/16/2026 | ||
| No record found. | |||||
| Load More | |||||
